Showing results (321-330 of 329) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 329 results.
Nature Communications|November 26, 2021
Efficacy and safety of next-generation tick transcriptome-derived direct thrombin inhibitorsCho Yeow Koh, Norrapat Shih, Christina Y C Yip, et al.
NEJM Evidence|February 6, 2024
Apixaban or Warfarin in Patients with an On-X Mechanical Aortic ValveTracy Y Wang, Lars G Svensson, Jun Wen, et al.
JAMA Cardiology|April 12, 2018
Association of Cardiomyopathy With MYBPC3 D389V and MYBPC3Δ25bpIntronic Deletion in South Asian DescendantsShiv Kumar Viswanathan, Megan J Puckelwartz, Ashish Mehta, et al.
Journal of Thrombosis and Thrombolysis|March 16, 2013
Highlights from the fifth international symposium of thrombosis and anticoagulation (ISTA V), October 18-19, 2012, Belo Horizonte, Minas Gerais, BrazilRenato D Lopes, Richard C Becker, L Kristin Newby, et al.
The American Journal of Medicine|April 30, 2016
North American Thrombosis Forum, AF Action Initiative Consensus DocumentChristian T Ruff, Jack E Ansell, Richard C Becker, et al.
Cardiovascular Research|February 16, 2019
Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary interventionThorsten Kessler, Bernhard Wolf, Niclas Eriksson, et al.
Journal of Thrombosis and Thrombolysis|May 7, 2011
Highlights from the III International Symposium of Thrombosis and Anticoagulation (ISTA), October 14-16, 2010, São Paulo, BrazilRenato D Lopes, Richard C Becker, John H Alexander, et al.
Lancet (London, England)|November 9, 2015
Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trialA Michael Lincoff, Roxana Mehran, Thomas J Povsic, et al.
JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.
Pageof 33